Osimert 80 mg
Osimertinib
Osimert 80mg Osimertinib is a kinase inhibitor used to treat EGFR mutation-positive non-small cell lung cancer (NSCLC) in adult patients. Taken orally under supervision.
- Strengths 80 mg
- Form Tablets
- Packaging Size 30 tablets
- Packaging Type Box
- Manufacturer Ziska Pharmaceutical
Description of Osimert 80 mg
Osimert 80mg Tablet contains Osimertinib, a third-generation tyrosine kinase inhibitor used for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations. It works by blocking abnormal proteins that signal cancer cell growth, helping to slow or stop the spread of the disease. Osimert 80mg is often prescribed for patients with metastatic or advanced stages of lung cancer. The medication is taken orally once daily and should be used under the guidance of a specialist. Regular health monitoring is necessary to track side effects and effectiveness during treatment.
Ingredients of Osimert 80 mg
- Osimertinib
Usage of Osimert 80 mg
- Oral use only
- Typically taken once daily
- Follow oncologist’s instructions precisely
Precautions for Osimert 80 mg
- Not for use in pregnancy or breastfeeding
- Monitor for heart and lung function regularly
- Report symptoms like shortness of breath or vision issues
- Avoid grapefruit and related products during therapy
More like this
Find related medicines from trusted suppliers. Explore similar products to ensure you get the right medication for your needs.
